Literature DB >> 18979540

A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?

Janet Chusainow1, Yuan Sheng Yang, Jessna H M Yeo, Poh Choo Toh, Parisa Asvadi, Niki S C Wong, Miranda G S Yap.   

Abstract

Generating stable, high-producing cell lines for recombinant protein production requires an understanding of the potential limitations in the cellular machinery for protein expression. In order to increase our understanding of what makes a stable high producer, we have generated a panel of 17 recombinant monoclonal antibody expressing Chinese hamster ovary subclones (CHO-mAb) with specific productivities ranging between 3 and 75 pg cell(-1) day(-1) using the dihydrofolate reductase (dhfr) expression system and compared the molecular features of these high- and low-producer clones. The relative heavy chain (HC) and light chain (LC) transgene copy numbers and mRNA levels were determined using real-time quantitative PCR (RT qPCR). We observed that not only higher transgene copy numbers and mRNA levels of both HC and LC were characteristic for the high-producer clones as compared to the low-producer clones but also a more favorable HC to LC transgene copy numbers ratio. By studying the long-term stability of the CHO-mAb subclones in the absence of methotrexate (MTX) selective pressure over 36 passages we observed a 35-92% decrease in volumetric productivity, primarily caused by a significant decrease in HC and LC mRNA levels with little change in the transgene copy numbers. Using Southern blot hybridization we analyzed the HC and LC transgene integration patterns in the host chromosome and their changes in course of gene amplification and long-term culturing. We observed that MTX-induced gene amplification caused chromosomal rearrangements resulting in clonal variability in regards to growth, productivity, and stability. No further obvious DNA rearrangements occurred during long-term culturing in the absence of MTX, indicating that other mechanisms were responsible for the decreased transcription efficiency. Our results implicate that the amplified transgene sequences were arranged in tandem repeats potentially triggering repeat-induced gene silencing. We hypothesize that the decline in transgene mRNA levels upon long-term culturing without MTX was mainly caused by transgene silencing consequently leading to a loss in mAb productivity. The exact molecular mechanisms causing production instability are not yet fully understood. The herein described extensive characterization studies could help understand the limitations to high-level, stable recombinant protein production and find ways to improving and accelerating the process for high-producer cell line generation and selection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18979540     DOI: 10.1002/bit.22158

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  73 in total

1.  Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.

Authors:  Katariina M Hutterer; Robert W Hong; Jonathon Lull; Xiaoyang Zhao; Tian Wang; Rex Pei; M Eleanor Le; Oleg Borisov; Rob Piper; Yaoqing Diana Liu; Krista Petty; Izydor Apostol; Gregory C Flynn
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

2.  Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells.

Authors:  Zeynep Betts; Alan J Dickson
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

3.  Correlation Between Expression of Recombinant Proteins and Abundance of H3K4Me3 on the Enhancer of Human Cytomegalovirus Major Immediate-Early Promoter.

Authors:  Benjamin P C Soo; Julian Tay; Shirelle Ng; Steven C L Ho; Yuansheng Yang; Sheng-Hao Chao
Journal:  Mol Biotechnol       Date:  2017-08       Impact factor: 2.695

4.  Dynamics of unfolded protein response in recombinant CHO cells.

Authors:  Kamal Prashad; Sarika Mehra
Journal:  Cytotechnology       Date:  2014-02-07       Impact factor: 2.058

5.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase.

Authors:  Chen Chen; Hui Liang; Xinmei Liao; Jian Pan; Jianhe Chen; Shibi Zhao; Yan Xu; Yun Wu; Jian Ni
Journal:  Tumour Biol       Date:  2016-10-04

7.  Toward stable gene expression in CHO cells.

Authors:  Esther Y C Koh; Jessna H M Yeo; Steven C L Ho; Yuansheng Yang
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

8.  Recurring genomic structural variation leads to clonal instability and loss of productivity.

Authors:  Arpan A Bandyopadhyay; Sofie A O'Brien; Liang Zhao; Hsu-Yuan Fu; Nandita Vishwanathan; Wei-Shou Hu
Journal:  Biotechnol Bioeng       Date:  2018-10-27       Impact factor: 4.530

9.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

10.  Recombinant protein expression by targeting pre-selected chromosomal loci.

Authors:  Kristina Nehlsen; Roland Schucht; Leonor da Gama-Norton; Wolfgang Krömer; Alexandra Baer; Aziz Cayli; Hansjörg Hauser; Dagmar Wirth
Journal:  BMC Biotechnol       Date:  2009-12-14       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.